Equipped with state-of-the-art instrumentation, the SCOT lab will facilitate early diagnosis, disease prognosis, biomarker discovery and drug screening across a spectrum of diseases – including cancer, cardiovascular, infectious, inflammatory, metabolic, and other non-communicable diseases, they said.
